| Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats |
28 |
| Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the Cardiac Benefits of Empagliflozin Independent of its Hypoglycemic Activity? |
16 |
| Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes |
15 |
| Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation |
14 |
| Pirfenidone in Heart Failure with Preserved Ejection Fraction-Rationale and Design of the PIROUETTE Trial |
14 |
| Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide |
11 |
| Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity? |
11 |
| The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway |
10 |
| Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol |
10 |
| Revisiting the Cardiotoxic Effect of Chloroquine |
10 |
| Dexmedetomidine Preconditioning Protects Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Necroptosis by Inhibiting HMGB1-Mediated Inflammation |
10 |
| Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction |
9 |
| New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors |
9 |
| Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon |
9 |
| Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies |
8 |
| GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials |
8 |
| Inhibition of Phosphoglycerate Mutase 5 Reduces Necroptosis in Rat Hearts Following Ischemia/Reperfusion Through Suppression of Dynamin-Related Protein 1 |
7 |
| Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial |
7 |
| Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation |
7 |
| Myocardial Slices: an Intermediate Complexity Platform for Translational Cardiovascular Research |
7 |
| Real World Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry |
7 |
| Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients |
6 |
| Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway |
6 |
| Perivascular Adipose Tissue: the Sixth Man of the Cardiovascular System |
6 |
| The Role of Thyroid Hormones in Heart Failure |
6 |
| Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients |
6 |
| Emerging Roles of Sympathetic Nerves and Inflammation in Perivascular Adipose Tissue |
6 |
| Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide |
6 |
| Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies |
6 |
| Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study) |
6 |
| Ticagrelor Versus Clopidogrel as Part of Dual or Triple Antithrombotic Therapy: a Systematic Review and Meta-Analysis |
6 |
| Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology |
5 |
| State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications |
5 |
| The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart |
5 |
| High-Density Lipoprotein Function and Dysfunction in Health and Disease |
5 |
| The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury |
5 |
| Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats |
5 |
| Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application |
5 |
| Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute |
4 |
| Sacubitril/Valsartan in Real-Life Practice: Experience in Patients with Advanced Heart Failure and Systematic Review |
4 |
| Remote Effects of Transplanted Perivascular Adipose Tissue on Endothelial Function and Atherosclerosis |
4 |
| MitoNEET in Perivascular Adipose Tissue Prevents Arterial Stiffness in Aging Mice |
4 |
| Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019 |
4 |
| Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study |
4 |
| Preconditioning by Levosimendan is Mediated by Activation of Mitochondrial Ca2+-Sensitive Potassium (mBK(Ca)) Channels |
4 |
| Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia |
4 |
| Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents |
4 |
| Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis |
4 |
| Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia |
3 |
| Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway |
3 |
